Myocarditis patent information

List of some medications that increase the risk of myocarditis listed in Sars-cov-2 vaccine patents.

1. Gilead
Methods for treating sars-cov-2 infections

2. Merck
Compounds for the treatment of viral infections

3. Janssen (pending)
SARS-CoV-2 Vaccines

4. Oxford
Compositions and methods for inducing an immune response

5. Rockefeller
Single-domain antibodies that bind sars-cov-2

6. Glaxosmithkline
Tripeptides derivatives for treating sars-cov-2 infections

7. US Army Cathepsin inhibitors for preventing or treating viral infections

Myocarditis linked to Covid-19 vaccines:

Other highlights

Cobalt (See also)

Lithium (See also)